Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 10/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 10/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 7/20 | 0.37 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | GRM8 | O00222 | 1/20 | 0.30 |
| ▸ | GRM6 | O15303 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | GRM5 | P41594 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.30 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.30 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5322605 | 1.00 | ALOX5 (0.38) | ALOX5SLC1A2SLC1A1SLC1A3SLC7A5 | |
| SCHEMBL3450600 | 0.86 | SLC7A5 (0.40) | ALOX5SLC1A2SLC1A1SLC1A3SLC7A5 | |
| SCHEMBL5580325 | 0.85 | ALOX5 (0.34) | ALOX5SLC1A2SLC1A1SLC1A3SLC7A5 | |
| SCHEMBL7621650 | 0.76 | EPHX1 (0.45) | SLC1A2SLC1A1SLC1A3EPHX1GRM2 | |
| SCHEMBL9321097 | 0.76 | SLC1A2 (0.36) | ALOX5SLC1A2SLC1A1SLC1A3SLC7A5 | |
| SCHEMBL7621655 | 0.76 | EPHX1 (0.45) | SLC1A2SLC1A1SLC1A3EPHX1GRM2 | |
| SCHEMBL24411126 | 0.73 | SLC1A2 (0.45) | ALOX5SLC1A2SLC1A1SLC1A3SLC7A5 | |
| SCHEMBL5320132 | 0.73 | SLC1A2 (0.45) | ALOX5SLC1A2SLC1A1SLC1A3SLC7A5 | |
| SCHEMBL22143593 | 0.73 | SLC1A2 (0.45) | ALOX5SLC1A2SLC1A1SLC1A3SLC7A5 | |
| SCHEMBL31688910 | 0.71 | SLC7A5 (0.40) | ALOX5SLC1A2SLC1A1SLC1A3SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | KARYON-CTT LTD (FI) | 2007-11-08 | — | — | US | disclosed |
| WO-2007113385-A1 | DIAGNOSTIC AND THERAPEUTIC AGENTS | KARYON-CTT LTD (FI) | 2007-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | YBX1, MLX, TPX2 | ALOX5 4116/4885SLC1A2 4787/4885SLC1A1 4654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.